ZYNRELEF — Full data
Q1 2027
As previously announced, registration batches have been manufactured and placed on stability, and the Company will receive 12-month stability data in the first quarter of 2027.Source filing
HRTX biotech catalysts & pipeline
HERON THERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
ZYNRELEF — Regulatory decision
Late 2027
Development of the proposed Prefilled Syringe market presentation is progressing and, if successful, FDA approval is anticipated in mid-to-late 2027.Source filing